Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical alpha-arbutin + kojic acid vs triple combination cream for melasma (split-face trial)
TCTR20230124004Phase 2Completed
- Sponsor
- St John's Institute of Dermatology
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluocinolone acetonide + hydroquinone + tretinoin in melasma, sponsored by St John's Institute of Dermatology. Started Apr 2022; status: completed.
02
Drugs
fluocinolone acetonide + hydroquinone + tretinoin
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20230124004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230124004.